Aton Ra Partners Tandem Diabetes Care Inc Transaction History

Aton Ra Partners

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$35.86 - $46.5 $37,222 - $48,267	-1,038 Reduced 12.33%	7,378 $299,000
Q4 2022 Feb 02, 2023	SELL	$35.49 - $56.15 $125,741 - $198,939	-3,543 Reduced 29.63%	8,416 $378,000
Q3 2022 Nov 14, 2022	SELL	$43.76 - $68.97 $100,604 - $158,562	-2,299 Reduced 16.12%	11,959 $572,000
Q2 2022 Aug 15, 2022	BUY	$53.22 - $123.09 $758,810 - $1.76 Million	14,258 New	14,258 $844,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Aton Ra Partners, based on Form 13F filings with the SEC.

Stay updated on Aton Ra Partners with notifications on news.